Skip to Main Content

Paper Details

Targeting homologous recombination deficiency in uterine leiomyosarcoma.
J Exp Clin Cancer Res
3
2023
(ADP-ribose), (ADP-ribose) polymerase, AZD5305, BRCA2, BRCA2-deleted PDX, COSMIC, DNA-PKcs, HR Deficiency, HR gene, HRD, HRD uLMS, PARP, PARP1, PARPi, PDX, PRKDC, Patient, Uterine leiomyosarcoma, cisplatin, gynaecological malignancy, homologous recombination deficiency, olaparib, patient, platinum, rare malignancy, uLMS, uterine leiomyosarcoma
Author NameAffiliation
Damien KeeWalter and Eliza Hall Institute of Medical Research
Damien KeePeter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne
Damien Kee
Damien Kee
Damien KeeOlivia Newton-John Cancer Research Institute
Stephen BarnettRoyal Melbourne Hospital
Stephen BarnettWestern Hospital
Sean M GrimmondUniversity of Melbourne
Sean M GrimmondUniversity of Melbourne
Anthony T PapenfussWalter and Eliza Hall Institute of Medical Research
Anthony T PapenfussUniversity of Melbourne
Anthony T PapenfussPeter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne
  • 1 - 12

Datasets

Release 1.2